Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

Results 1-7 of 7 (Search time: 0.004 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2017HIF-2α promotes dissemination of plasma cells in multiple myeloma by regulating CXCL12/CXCR4 and CCR1Vandyke, K.; Zeissig, M.; Hewett, D.; Martin, S.; Mrozik, K.; Cheong, C.; Diamond, P.; To, L.; Gronthos, S.; Peet, D.; Croucher, P.; Zannettino, A.
2017Cutting edge genomics reveal new insights into tumour development, disease progression and therapeutic impacts in multiple myelomaDutta, A.; Hewett, D.; Fink, J.; Grady, J.; Zannettino, A.
2017DNA barcoding reveals habitual clonal dominance of myeloma plasma cells in the bone marrow microenvironmentHewett, D.; Vandyke, K.; Lawrence, D.; Friend, N.; Noll, J.; Geoghegan, J.; Croucher, P.; Zannettino, A.
2017Sphingosine kinase 2 inhibition synergises with bortezomib to target myeloma by enhancing endoplasmic reticulum stressWallington-Beddoe, C.; Bennett, M.; Vandyke, K.; Davies, L.; Zebol, J.; Moretti, P.; Pitman, M.; Hewett, D.; Zannettino, A.; Pitson, S.
2019Subclonal evolution in disease progression from MGUS/SMM to multiple myeloma is characterised by clonal stabilityDutta, A.; Fink, J.; Grady, J.; Morgan, G.; Mullighan, C.; To, L.; Hewett, D.; Zannettino, A.
2015Tetraspanin 7 (TSPAN7) expression is upregulated in multiple myeloma patients and inhibits myeloma tumour development in vivoCheong, C.; Chow, A.; Fitter, S.; Hewett, D.; Martin, S.; Williams, S.; To, L.; Zannettino, A.; Vandyke, K.
2015Therapeutic targeting of N-cadherin is an effective treatment for multiple myelomaMrozik, K.; Cheong, C.; Hewett, D.; Chow, A.; Blaschuk, O.; Zannettino, A.; Vandyke, K.